Zobrazeno 1 - 10
of 24 861
pro vyhledávání: '"Hbsag"'
Autor:
DENG Yanqing, WAN Zhiting, HUANG Boquan, LIANG Haojian, DU Rongsong, LI Zhongping, ZHENG Jianting, XU Ru, WANG Min, WANG Hao
Publikováno v:
Zhongguo shuxue zazhi, Vol 37, Iss 11, Pp 1301-1306 (2024)
[Objective] To analyze the influence of the cycle length of hepatitis B surface antigen (HBsAg) double reagent positive samples collected from voluntary blood donors in Guangzhou on the detection results. [Methods] A total of 127 044 blood samples fr
Externí odkaz:
https://doaj.org/article/a1aae9ea48a14ef8a62e687e261904d1
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-7 (2024)
Abstract Background The best antiviral treatment for chronic hepatitis B (CHB) poses a complex challenge. The treatment effect of the combination of nucleoside analogues (NAs) and pegylated interferon alpha (PegIFN) was still in debate. Methods We st
Externí odkaz:
https://doaj.org/article/f055a74a609d4dee91b82fa7e2b7baa9
Publikováno v:
International Journal of General Medicine, Vol Volume 17, Pp 4669-4680 (2024)
Zhongbao Zuo,1,* Jing Wu,1,* Miaochan Wang,1 Rui Wu,2 Xiaojing Zhang,2 Lanlan Hu,1 Huaizhong Cui,1 Ting Feng,3 Aifang Xu,1 Shourong Liu2 1Department of Clinical Laboratory, Hangzhou Xixi Hospital, Zhejiang, 310023, People’s Republic of Chin
Externí odkaz:
https://doaj.org/article/b2c453b0045743bb8c1bea944226283b
Publikováno v:
Virology Journal, Vol 21, Iss 1, Pp 1-14 (2024)
Abstract Background Hepatitis B surface antigen (HBsAg) loss is regarded as a pivotal criterion for assessing functional cure in patients diagnosed chronic hepatitis B (CHB). We conducted the research to investigate the real-world performance of HBsA
Externí odkaz:
https://doaj.org/article/55082c31e9ca4210a6a6d7c33eaec95e
Autor:
Xiaodi Li, Ling Xu, Lianfeng Lu, Xiaosheng Liu, Yang Yang, Yuanni Wu, Ting Zhu, Xiaoxia Li, Yanling Li, Xiaojing Song, Yang Han, Wei Lyu, Wei Cao, Taisheng Li
Publikováno v:
Journal of Translational Medicine, Vol 22, Iss 1, Pp 1-12 (2024)
Abstract Background Several studies have reported that combination antiretroviral therapy (cART) enhances the hepatitis B surface antigen (HBsAg) clearance rate in Human Immunodeficiency Virus-1/Hepatitis B Virus (HIV/HBV) coinfected patients, yet th
Externí odkaz:
https://doaj.org/article/adfd764866b3485c804265ba9299c141
Autor:
Lina Wu, Jiadi Lai, Qiumin Luo, Yeqiong Zhang, Chaoshuang Lin, Dongying Xie, Youming Chen, Hong Deng, Zhiliang Gao, Liang Peng, Wenxiong Xu
Publikováno v:
Liver Research, Vol 8, Iss 3, Pp 179-187 (2024)
Background and aim: Few studies have reported hepatitis B surface antigen (HBsAg) kinetics after nucleos(t)ide analog (NA) discontinuation in patients with noncirrhotic chronic hepatitis B (CHB). The study specifically investigated long-term HBsAg ki
Externí odkaz:
https://doaj.org/article/415b38de27784d988b5083a1ef4ab88c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Clinical significance of cytokine levels in HBsAg sero-clearance in patients with severe hepatitis B
Publikováno v:
陆军军医大学学报, Vol 46, Iss 16, Pp 1913-1919 (2024)
Objective To explore the clinical significance of serum cytokine expression in the hepatitis B surface antigen (HBsAg) sero-clearance in patients with severe hepatitis B. Methods A nested case-control trial was conducted on 14 inpatients with severe
Externí odkaz:
https://doaj.org/article/fe843079ab844fd6af9d6cd5215c70d7
Autor:
N. V. Vlasenko, M. D. Chanyshev, A. V. Peresadina, A. A. Grishaeva, T. A. Semenenko, A. V. Snitsar, L. V. Lyalina, S. N. Kuzin, K. F. Khafizov, V. G. Akimkin
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 23, Iss 3, Pp 76-87 (2024)
Relevance. It is known that the immune response to the administration of immunobiological drugs is variable and depends on the individual characteristics of the organism. Host immunogenetic factors have a significant impact on the effectiveness of va
Externí odkaz:
https://doaj.org/article/291ec4fca142457cba9198db84635883
Publikováno v:
Nigerian Journal of Paediatrics, Vol 44, Iss 3, Pp 136-139 (2024)
Introduction: Hepatitis B virus infection is a major public health problem worldwide. It is more infectious and more in Nigeria than the Human Immunodeficiency Virus (HIV). It is a major risk factor for the development of liver cirrhosis and hepatoce
Externí odkaz:
https://doaj.org/article/a685df4fd6af4ef88086523112f6f8f5